생화학분자생물학회입니다.
Engineered human cardiac tissues for modeling heart diseases
작성자
Seung-Woo Cho작성일자
2022-12-22조회수
969Name: Seung-Woo Cho ( seungwoocho@yonsei.ac.kr ) | ||
2020-present | Underwood Distinguished Professor, Yonsei University | |
2017-present | Associate faculty, Institute for Basic Science (IBS) | |
2010-present | Professor, Department of Biotechnology, Yonsei University | |
2007-2010 | Postdoctoral associate, Department of Chemical Engineering, Massachusetts Institute of Technology, USA | |
1995-2006 | B.S., M.S., Ph.D., Chemical Engineering, Seoul National University |
Engineered human cardiac tissues for modeling heart diseases
Heart disease is one of the major life-threatening diseases with high mortality and incidence worldwide. Several model systems, such as primary cells and animals, have been used to understand heart diseases and establish appropriate treatments. However, they have limitations in accuracy and reproducibility in recapitulating disease pathophysiology and evaluating drug responses. In recent years, three-dimensional (3D) cardiac tissue models produced with tissue engineering and human cells have outperformed conventional models. In particular, integration of cell reprogramming technique with bioengineering platforms (e.g., microfluidics, scaffolds, bioprinting, biophysical stimuli) has facilitated development of heart-on-a-chip, cardiac spheroid/organoid, and engineered heart tissue (EHT) to recapitulate structural and functional features of native human heart. These cardiac models have improved heart disease modeling and toxicological evaluation. In this review, we summarize the cell types for fabrication of cardiac tissue models, introduce diverse 3D human cardiac tissue models, and discuss the strategies to enhance their complexity and maturity. Finally, recent studies to model various heart diseases are reviewed.
BMB Rep. 2022 Nov 29;5794. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36443005/